Companies: 10,795·Total market cap: $144.5T
Acrivon Therapeutics, Inc. Common Stock

Acrivon Therapeutics, Inc. Common Stock

ACRVNASDAQHealthcare● Active
$1.45
+$0.04(+2.84%)
Market Cap$45756420
P/E Ratio
52W High$3.56
52W Low$1.15
Overview

Acrivon Therapeutics, Inc. Common Stock (ACRV) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ACRV · as of Mar 19, 2026

Latest filing snapshot

74
-1-1.33%vs prior year

Acrivon Therapeutics, Inc. Common Stock (ACRV) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
74
Change (1Y)
-1
Growth % (1Y)
-1.33%
Revenue / Employee
Net Income / Employee
$-1.05M
Market Cap
$46M

ACRV Employee Count

2022 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-1974-1-1.33%
2025-03-2775+17+29.31%
2024-03-2858+17+41.46%
2023-03-2841

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Cibus, Inc.
CBUS
Cibus, Inc.
157
#2
Immunic, Inc.
IMUX
Immunic, Inc.
91
#3
Biomea Fusion, Inc.
BMEA
Biomea Fusion, Inc.
79
#4
Acrivon Therapeutics, Inc. Common Stock
ACRV
Acrivon Therapeutics, Inc. Common StockYOU
74
#5
aTyr Pharma, Inc.
ATYR
aTyr Pharma, Inc.
56
#6
PMV Pharmaceuticals, Inc.
PMVP
PMV Pharmaceuticals, Inc.
47
#7
Relmada Therapeutics, Inc.
RLMD
Relmada Therapeutics, Inc.
17
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ACRV peer comparison

About ACRV employees

ACRV Employees · Headcount

Acrivon Therapeutics, Inc. Common Stock (ACRV) employee data is sourced from the annual SEC 10-K filing. As of 2025, Acrivon Therapeutics, Inc. Common Stock had 74 full-time employees globally. Full-time employees only. Global consolidated headcount.

Acrivon Therapeutics, Inc. Common Stock's workforce decreased by 1 (1.33%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Frequently Asked Questions

ACRV Employees · 5 questions

As of the latest SEC 10-K filing (2025), Acrivon Therapeutics, Inc. Common Stock had 74 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Acrivon Therapeutics, Inc. Common Stock employee counthow many employees does Acrivon Therapeutics, Inc. Common Stock haveACRV total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-19